𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified

✍ Scribed by Agustin Avilés; Claudia Castañeda; Natividad Neri; Sergio Cleto; Alejandra Talavera; Martha González; Judith Huerta-Guzmán; M. Jesús Nambo


Book ID
107576678
Publisher
Springer US
Year
2008
Tongue
English
Weight
142 KB
Volume
25
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Clinical relevance of immunophenotype in
✍ Fortunato Morabito; Andrea Gallamini; Caterina Stelitano; Vincenzo Callea; Cesar 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

## Abstract ## BACKGROUND To assess the impact of T‐cell/B‐cell phenotype on clinical outcome, the authors retrospectively compared patients who had peripheral T‐cell lymphoma, unspecified (PTCL‐U), with patients who had diffuse large B‐cell lymphoma (DLBCL). ## METHODS Two hundred ninety‐seven

Alternating chemoradiotherapy versus par
✍ Renzo Corvò; Marco Benasso; Giuseppe Sanguineti; Rita Lionetto; Almalina Bacigal 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 1 views

## BACKGROUND. The authors previously have found that in patients with locally advanced squamous cell carcinoma of the head and neck (SCC-HN), alternating chemoradiotherapy (ALT) was superior to low-total-dose conventional radiotherapy alone. The purpose of this randomized trial was to compare the